- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterNCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - February 2002
National Cancer Institute®
Last Modified: February 1, 2002
Table of Contents
1
UI - 11685963
AU - Mevio E; Bignami M; Luinetti O; Villani L
TI -
Nasal paraganglioma. A case report.
SO - Acta Otorhinolaryngol Belg 2001;55(3):247-9
AD - Service de ORL, Hopital G. Fornaroli, Magenta (Mi), Pavia, Italy.
emevio@libero.it
Nasal paraganglioma. A case report. Nonchromaffin paragangliomas or
chemodectomas arise in paraganglia distributed in various parts of the
body. The jugular bulb, the vagal body and the bifurcation of the
carotid artery are the most common sites of origin of paraganglioma in
the head and neck region. Paragangliomas in the nose and paranasal
sinuses are extremely rare and very few cases of definite paraganglioma
arising primarily in the nose or paranasal sinuses have been reported.
The paraganglioma is a slow-growing tumour that produces nasal
obstruction, profuse epistaxis and facial swelling. Complete excision of
the glomus tumour is normally curative. We report a case of nasal
paraganglioma and discuss the diagnosis and therapy.
2
UI - 11685964
AU - Monserez D; Vlaminck S; Kuhweide R; Casselman J
TI -
Symmetrical ethmoidal metastases from ductal carcinoma of the breast,
suggesting transcribrosal spread.
SO - Acta Otorhinolaryngol Belg 2001;55(3):251-7
AD - ENT Department, A.Z. St. Jan, Brugge, Belgium.
Symmetrical ethmoidal metastases from ductal carcinoma of the breast,
suggesting transcribrosal spread. While half of breast cancers develop
metastases, the appearance of metastatic disease in paranasal sinuses
from this origin is very rare. Eighteen other cases were found in the
literature, dating from 1939 till now. A case of metastatic breastcancer
presenting as a subacute therapy-resistant pansinusitis is described.
The perfect symmetry was misleading. Bilateral ethmoidal biopsies were
compatible with metastases from a ductal adenocarcinoma. Further
investigation revealed meningeal carcinomatosis in the supra-orbital
region and locoregional recurrence in the mastectomy scar and axilla.
Comparing these 19 cases in chronological order, it was noticed that
symptoms at time of diagnosis shift from those of space occupying
lesions to those suggestive for sinusitis. This shift could be explained
by earlier diagnosis. High index of suspicion is the key to diagnosis.
Earlier diagnosis does not result in longer survival since in most cases
patients have already widespread disease and die within one year. Most
authors mention the role of the vertebral venous plexus in hematogeneous
spreading of tumor cells. Another pathway of hematogenous spread is via
(occult) lung metastases. This case prompts the hypothesis of
transcribrosal spread from meningeal involvement.
3
UI - 11774402
AU - Snyder ML; Paulino AF
TI -
Melan-A as a useful diagnostic immunohistochemical stain for the
diagnosis of primary sinonasal melanomas.
SO - Head Neck 2002 Jan;24(1):52-5
AD - Department of Pathology, University of Michigan Hospitals, 1500 East
Medical Center Drive, Room 2G332, Ann Arbor, MI 48109, USA.
BACKGROUND: Sinonasal melanomas are rare neoplasms whose diagnosis may
require confirmatory immunohistochemical stains. S-100 protein and
HMB-45, the stains most commonly used, have varying sensitivities and
specificities. Melan-A, a more recent melanoma-specific marker, may
prove helpful when S-100 protein and HMB-45 stains are negative or
equivocal. METHODS: Seven cases of sinonasal melanoma were assessed for
reactivity with Melan-A, S-100 protein and HMB-45. RESULTS: The study
group consisted of two women and five men ages 40 to 83. Six of the
neoplasms were strongly positive for S-100 protein. One case was
negative for S-100 protein and HMB-45 but positive for Melan-A. HMB-45
staining varied between diffusely positive (three cases), focally
positive (two cases), and negative (two cases). All cases were positive
for Melan-A either diffusely (four cases) or focally (three cases).
CONCLUSION: Because Melan-A can be positive in cases that are S-100
protein or HMB-45 negative, it is a useful component in the
immunohistochemical panel for the diagnosis of sinonasal melanomas.
Copyright 2002 John Wiley & Sons, Inc.
4
UI - 11815971
AU - Yasumatsu R; Nakashima T; Kuratomi Y; Hirakawa N; Azuma K; Tomita K;
TI -
Cataltepe S; Silverman GA; Clayman GL; Komiyama S
Serum squamous cell carcinoma antigen is a useful biologic marker in
patients with inverted papillomas of the sinonasal tract.
SO - Cancer 2002 Jan 1;94(1):152-8
AD - Department of Otorhinolaryngology, Faculty of Medicine, Kyushu
University, Fukuoka, Japan.
BACKGROUND: Inverted papilloma (IP) is a frequent benign sinonasal tumor
that is characterized histologically by squamous metaplasia, epithelial
acanthosis, and hyperplasia of the nasal epithelium. Because of its high
recurrence rate and malignant transformation potential, careful
long-term follow up is necessary. METHODS: The purpose of the current
report was to study the expression of squamous cell carcinoma (SCC)
antigen in sinonasal IPs and to evaluate the usefulness of SCC antigen
as a biologic marker for the follow-up of patients with sinonasal IP.
The expression of SCCA1 in three sinonasal IP cases, three sinonasal SCC
cases, and cases of normal nasal epithelium were examined by Western
blot analysis, and the SCCA1 expression pattern in 31 IP specimens and 4
carcinoma in IP specimens were evaluated immunohistochemically. The
serum levels of SCC antigen in 11 patients with sinonasal IP also were
analyzed. RESULTS: SCCA1 was overexpressed in all three sinonasal IP
tissues compared with sinonasal SCC tissues or normal nasal epithelium.
SCCA1 cytoplasmic immunoreactivity was detected in the suprabasal
epidermal keratinocytes of all 31 sinonasal IP cases. In the four
carcinoma in IP specimens, SCCA1 expression in the papillomatous lesion
was more intense than in the cancerous lesion. The serum SCC antigen
level was high in 10 of 11 patients with IP (91%) and significantly
decreased after surgical resection of the tumors. CONCLUSIONS: The
results of the current study indicate that SCCA1 frequently is
overexpressed and may play a biologic role in the development of
sinonasal IPs. Serum SCC antigen may be a useful biologic marker in
patients with sinonasal IP. Copyright 2002 American Cancer Society.
5
UI - 11554623
AU - Quraishi MS; Bessell EM; Clark DM; Jones NS; Bradley PJ
TI -
Aggressive sino-nasal non-Hodgkin's lymphoma diagnosed in
Nottinghamshire, UK, between 1987 and 1996.
SO - Clin Oncol (R Coll Radiol) 2001;13(4):269-72
AD - University Hospital, Nottingham, UK.
In the 10-year period 1987 to 1996, 24 patients were diagnosed with
aggressive non-Hodgkin's lymphoma of the nasal cavities or paranasal
sinuses. The disease occurred in a relatively elderly population of
median age 72 years (range 42 to 96) with a male predominance (male 15;
female nine). The histology on review was mostly of the large B-cell
subtype (21 patients); peripheral T-cell subtype (one), anaplastic large
cell of T-cell type (one) and T/natural killer cell nasal lymphoma
(one). The disease was localized in 20 patients (Stage IEA). The overall
survival at 5 years was 40% (95% confidence interval (CI) 19-61); at 10
years it was 33% (95% CI 12-54). The cause-specific survival (excluding
deaths from causes other than lymphoma) at 5 years and 10 years was 62%
(95% CI 39-86).
6
UI - 11730998
AU - Claus F; De Gersem W; Vanhoutte I; Duthoy W; Remouchamps V; De Wagter C;
TI -
De Neve W
Evaluation of a leaf position optimization tool for intensity modulated
radiation therapy of head and neck cancer.
SO - Radiother Oncol 2001 Dec;61(3):281-6
AD - Division of Radiotherapy, Ghent University Hospital (GUH), De Pintelaan
185, 9000 Ghent, Belgium.
BACKGROUND AND PURPOSE: Since 1996, patients are treated at Ghent
University Hospital with a multi-segment technique using MultiLeaf
Collimators. The segments were obtained by using the Beam's eye view
projections of the planning target volume (PTV) and the organs at risk
(OARs), after which the segments weights were optimized. To investigate
if optimization of the leaf positions would further improve the
intensity modulated radiation therapy (IMRT) plans, a tool optimizing
leaf positions and segment weights simultaneously, was developed. This
tool is called SOWAT, which is the acronym for segment outline and
weight adapting tool. MATERIAL AND METHODS: The tool evaluates the
effects of changing the position of each collimating leaf of all
segments on the value of the objective function. Only changes that
improve the value of the objective function are retained. Between
with IMRT. Two patient groups were distinguished: pharyngeal and
laryngeal tumors (n=17) and sinonasal tumors (n=13). A specific set of
physical endpoints was evaluated for each group. Dose statistics of the
treatment plans without and with SOWAT were analyzed. RESULTS: When
using SOWAT for the pharyngeal and laryngeal cases, the PTV dose
homogeneity increased with a median of 11% (range 2-27%), while the
maximum dose to the spinal cord was decreased for 14 of the 17 patients.
In four plans where parotid function preservation was a goal, the
parotid mean dose was lower than 26 Gy in one plan without SOWAT, and in
four plans with SOWAT. For the sinonasal tumors, the PTV dose
homogeneity increased with a median of 7% (range 1-14%). SOWAT lowered
the mean dose to 53 of the 63 optic pathway structures (retina, optic
nerve and optic chiasm). SOWAT leaves the number of segments unchanged
and has little or no effect on the delivery time. CONCLUSIONS: SOWAT is
a powerful tool to perform the final optimization of IMRT plans, without
increasing the complexity of the plan or the delivery time.
7
UI - 11773735
AU - Pokorny JJ; Roth F; Balfour I; Rinehart G
TI -
An unusual complication of the treatment of a hemangioma.
SO - Ann Plast Surg 2002 Jan;48(1):83-7
AD - Division of Plastic Surgery, St. Louis University Hospital, 3635 Vista
at Grand Boulevard, St. Louis, MO 63110, USA.
A 3-month-old infant was administered high-dose systemic prednisolone
for management of a hemangioma of the nasal sidewall. After 10 weeks of
therapy, medical evaluation of weight loss disclosed hypertrophic
obstructive cardiomyopathy. After discontinuation of the steroid, the
cardiomyopathy resolved.
8
UI - 11802063
AU - Besancon-Watelet C; Bene MC; Montagne P; Faure GC; Jankowski R
TI -
Eosinophilia and cell activation mediators in nasal secretions.
SO - Laryngoscope 2002 Jan;112(1):43-6
AD - Laboratoire d'Immunologie du CHU, Faculte de Medecine, 54505,
Vandoeuvre-les-Nancy Cedex, France.
OBJECTIVES/HYPOTHESIS: In rhinologic disorders such as polyposis or
rhinitis, nasal cytology allows differentiation between patients
according to the degree of eosinophilia in nasal secretions. The egress
of eosinophil and/or neutrophil polymorphonuclears from the underlying
mucosa might correlate with the release of soluble mediators of cell
activation such as the chemokine IL-8, and such molecules of the innate
immunity as the LPS-receptor CD14 or lysozyme. We assayed the levels of
these three molecules in nasal secretions in correlation with cytologic
findings and especially the degree of eosinophilia. STUDY DESIGN:
Fifty-four patients from a prospective study of nasal secretions were
enrolled in this work. They constituted two groups of 27 patients each,
respectively, with or without more than 20% eosinophils in nasal
secretions. Nasal secretions were collected by aspiration, weighed and
diluted in a fixed amount of buffer. Classic cytologic analyses were
performed on the pelleted cells and IL-8, sCD14, and lysozyme levels
were assayed in the cell-free supernatants. METHODS: Cytologic analyses
included cell-enumeration in Neubauer's chambers, and differentials
performed on May-Grunwald Giemsa-stained cytospins. ELISA tests were
used to assay the levels of IL-8 and sCD14. Lysozyme concentrations were
assayed in immuno-nephelometry. RESULTS: Significantly lower levels of
IL-8 and sCD14 were observed in patients with eosinophilia than in
patients with a predominance of neutrophils, whereas no difference was
observed in lysozyme concentrations. CONCLUSION: These data show that
the egress of neutrophils in nasal secretions is associated with high
levels of IL-8 and sCD14.
9
UI - 11802038
AU - Takeno S; Hirakawa K; Ueda T; Furukido K; Osada R; Yajin K
TI -
Nuclear factor-kappa B activation in the nasal polyp epithelium:
relationship to local cytokine gene expression.
SO - Laryngoscope 2002 Jan;112(1):53-8
AD - Department of Otolaryngology, Hiroshima University School of Medicine,
Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, Japan.
Sachio.Takeno@ma2.seikyou.ne.jp
OBJECTIVES: A panel of cytokines has been found to be important for
eosinophil accumulation and activation in nasal polyps. The aims of this
study were to ascertain whether the activation of nuclear factor-kappa B
(NF-kappaB) occurred in the polyp epithelium, and to examine the
relationship between the degree of activation and local cytokine gene
expression. STUDY DESIGN/METHODS: Nasal polyp specimens were obtained
from 26 untreated patients. The proportion of nuclear translocation of
the NF-kappaB p50 subunit in the polyp epithelium was quantitatively
analyzed by a combination of fluorescent immunohistochemistry and a
laser scanning confocal microscope image system. The levels of GM-CSF,
IL-5, IL-8, IL-16, and eotaxin mRNA expression in the same speci-mens
were measured using reverse transcription-polymerase chain reaction.
RESULTS: Both cytoplasmic and nuclear localization of the p50 subunit
was observed mainly in the epithelial layer in all specimens. The
percentages of epithelial cells with nuclear translocation ranged from
4.5% to 40.5% (median, 18%). Significant correlations were observed
between the degree of epithelial NF-kappaB activation and the levels of
IL-8, IL-16, and eotaxin mRNA expression (r = 0.468, 0.47, and 0.739,
respectively). CONCLUSION: The activation of NF-kappaB in the nasal
polyp epithelium is responsible for the recruitment of inflammatory
cells, particularly eosinophils, through the initiation of the
transcriptional pathway of the related cytokines. The increased
NF-kappaB activity in the polyp epithelium may reflect hypersensitivity
to unknown stimuli.
10
UI - 11801944
AU - Hong SK; Min YG; Kim CN; Byun SW
TI -
Endoscopic removal of the antral portion of antrochoanal polyp by
powered instrumentation.
SO - Laryngoscope 2001 Oct;111(10):1774-8
AD - Department of Otolaryngology, College of Medicine, Ewha Women's
University Mokdong Hospital, Seoul, Korea. soonkwan@unitel.co.kr
OBJECTIVES: To introduce a new surgical technique for endoscopic removal
of the antral portion of antrochoanal polyp (ACP) by powered
instrumentation and to determine its efficacy by measures of relevant
patient outcome. STUDY DESIGN: Prospective study in 28 patients
undergoing endoscopic sinus surgery for ACP by our surgical technique.
METHODS: Improvements of clinical symptoms and endoscopic and computed
tomographic findings were evaluated postoperatively with a follow-up
period ranging from 12 to 52 months. All symptom scores on a 100-mm
visual analogue scale before operation were compared with those at the
last visit after operation. Postoperative endoscopic and computed
tomographic findings were graded using a three-point scale ranging from
0 to 2. In surgical technique, the antral portion of ACP was identified
through the enlarged ostium under intranasal endoscopy and removed by a
blade of powered instrumentation that was inserted through the canine
fossa. RESULTS: Symptom scores were all significantly reduced
postoperatively. All but one patient showed improvement in clinical
symptoms and endoscopic and computed tomographic findings during the
follow-up period. There were no major complications specific to this
technique. CONCLUSION: Our technique provides an attractive alternative
to other methods for removing the antral portion of an ACP and is
associated with excellent outcomes and minimal morbidities.
11
UI - 11141953
AU - Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M;
TI -
Baggiolini M; Williams TJ; Conroy DM
[The role of chemokines in nasal polyps]
SO - Schweiz Med Wochenschr 2000;Suppl 125():92S-95S
AD - Universitatsklinik fur HNO, Hals- und Kopfchirurgie, Inselspital Bern.
Nasal polyposis is an inflammatory condition of the nose and the sinuses
characterised by a marked infiltration of eosinophils in addition to
lymphocytes, mast cells and macrophages. The selective recruitment of
eosinophils to inflammatory sites is mediated by CC chemokines such as
Eotaxin and Eotaxin-2. In the present study histology,
immunohistochemistry and ELISA were performed. The levels of Eotaxin and
Eotaxin-2 and for comparison other chemokines RANTES and IL-8 were
measured in nasal polyp tissue and in control nasal tissue. On
histological examination 6 polyps showed an oedematous structure, one
was glandular and one had a fibromatous pattern, while all showed a
marked eosinophil infiltration. Immunohistochemistry of the polyps
showed that epithelial cells were strongly positive for Eotaxin and
IL-8, whereas endothelial cells stained positive for Eotaxin-2.
Significantly higher amounts of Eotaxin, Eotaxin-2 and IL-8 were
detected in polyp tissue when compared with control middle turbinates.
The increased levels of eosinophil-stimulating chemokines, such as
Eotaxin and Eotaxin-2 in nasal polyps suggest that they may be important
regulators of eosinophil recruitment in this inflammatory disease.
12
UI - 11506340
AU - Adanali G; Ayhan M; Gorgu M; Erdogan B
TI -
Nasal bone destruction by a cavernous hemangioma in an elderly patient.
SO - Ann Plast Surg 2001 Aug;47(2):216-7
13
UI - 11780191
AU - Zong Y; Liu K; Zhong B; Chen G; Wu W
TI -
Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in
Guangzhou.
SO - Chin Med J (Engl) 2001 Feb;114(2):132-6
AD - Department of Pathology, Sun Yat-sen University of Medical Sciences,
Guangzhou 510089, China. pathol@gzsums.edu.cn
OBJECTIVES: To investigate the prevalence of sinonasal lymphoepithelial
carcinoma (SNLEC) in Guangzhou, a high incidence area of nasopharyngeal
carcinoma (NPC), and to detect whether it is associated with
Epstein-Barr virus (EBV) infection. METHODS: Twenty confirmed SNLEC
specimens were collected from all of the sinonasal carcinoma biopsies
performed in the 8 years 1989-1996 at the Sun Yat-sen University of
Medical Sciences. EBV encoded early RNAs were detected by use of in-situ
hybridization. A variety of antigens, including the EBV nuclear antigen
1, latent membrane protein 1, BZLF1 protein, diffuse early antigen,
viral capsid antigen and membrane antigen, were detected using
immunohistochemistry. Additionally, 36 NPC specimens were used for
comparison. RESULTS: Twenty SNLECs were identified. Seventeen SNLECs
were developed in the nasal cavity, and 3 in the maxillary sinus. The
mean age (46.25 y), male to female ratio (3:1), histopathology and
lymphoinfiltration of the 20 SNLECs were identical with those of the 36
NPCs. Thirteen (65.0%) of the 20 SNLECs showed an expansive growth
pattern, while 27 (75.0%) of the 36 NPCs showed an infiltrating or mixed
growth pattern. The majority of cancer cells in all of the 20 SNLECs
showed EBV encoded early RNAs. The EBV nuclear antigen 1 expression of
SNLEC was less intensive than that of NPC. The expression rate of latent
membrane protein 1 for SNLEC (3/20, 15%) was lower than that for NPC
(19/36, 52.8%). The expression rates of BZLF1 protein (2/20, 10.0%),
diffuse early antigen (19/20, 95.0%), viral capsid antigen (15/20,
75.0%), and membrane antigen (13/20, 65.0%) for SNLEC were higher than
those (0/36, 0.0%; 31/36, 86.0%; 18/36, 50%; and 14/36, 38.9%) for NPC.
CONCLUSIONS: SNLEC is not uncommon in Guangzhou. This tumour is also
consistently associated with EBV infection like NPC. As compared to NPC,
the EBV harbored in SNLECs seems to express the EBV nuclear antigen 1
weakly and has a lower expression rate of latent membrane protein 1 as
well as higher expression rates of EBV lytic products.
14
UI - 11579720
AU - Mavragani CP; Paikos S; Doussis-Anagnostopoulou I; Voulgarelis M
TI -
Midfacial swelling and oro-nasal involvement in a 53-year-old patient
with bilateral pulmonary infiltrations.
SO - Clin Exp Rheumatol 2001 Sep-Oct;19(5):577-81
AD - Department of Pathophysiology, Medical School, National University of
Athens, Greece.
15
UI - 11721507
AU - Keles N; Deger K
TI -
Endonasal endoscopic surgical treatment of paranasal sinus inverted
papilloma--first experiences.
SO - Rhinology 2001 Sep;39(3):156-9
AD - Department of ORL, Istanbul School of Medicine, Istanbul University,
Turkey. nkeles@e-kolay.net
PURPOSE: Surgical excision is generally regarded as the treatment of
choice for inverted papilloma. However, the approach and extent of
surgery has been subject of much debate. The purpose of this study is to
evaluate the results of endoscopic sinus surgery in the treatment of
paranasal sinus inverted papilloma. PATIENTS AND METHODS: Thirteen cases
of inverted papilloma of the paranasal sinuses treated via endoscopic
sinus surgery were evaluated. The follow-up averaged from 9 months to 48
months with a mean of 27 months. RESULTS: A close follow-up of all
patients was maintained. Seventy-seven per cent (10/13) of the patients
had no recurrence after the initial endoscopic procedure. Three patients
had recurrences of their tumor within 11 months after surgery, which
means a rate of 23% (3/13). In 2 patients, the recurrences were treated
endoscopically. In one patient, recurrence and malignant transformation
(squamous cell carcinoma) developed after 36 months, which means that
the associated carcinoma rate was 7% (1/13). This patient underwent
radical maxillectomy and postoperative radiotherapy. None of the
patients died of inverted papilloma. CONCLUSION: Endoscopic sinus
surgery is a viable treatment alternative for paranasal sinus inverted
papilloma in selected cases. This approach should be performed by
experienced surgeons and a close follow-up is mandatory. When the
disease is more extensive, it should be approached by radical surgery,
e.g. en-bloc excision by medial maxillectomy via lateral rhinotomy or
mid-facial degloving.
16
UI - 11721510
AU - Yang TL; Hsu MC; Liu CM
TI -
Nasal schwannoma: a case report and clinicopathologic analysis.
SO - Rhinology 2001 Sep;39(3):169-72
AD - Department of Otolaryngology, National Taiwan University Hospital,
Taipei, Taiwan.
According to the literature, half of the schwannoma cases occur in the
head and neck areas and only less than 4% occur in the sinonasal tract.
In this case, a 39-year-old male patient, with a-year-long progressive
left side nasal obstruction and purulent rhinorrhea, is presented. The
CT reveals a mass filling the left nasal cavity and nasopharyngeal
space, with bony erosion of the inferior turbinate and medial maxillary
bone. During surgical intervention, the mass is found to originate from
the medial side of the left middle turbinate with maxillary sinusitis
and inferior turbinate atrophy. The pathological examination reveals a
noncapsulated tumor with palisading cellular arrangement and high
cellular density. The pathological findings and nervous origin of the
tumor are discussed after an extensive review of the literature.
17
UI - 11719871
AU - Verney Y; Zanolla G; Teixeira R; Oliveira LC
TI -
Midline nasal mass in infancy: a nasal glioma case report.
SO - Eur J Pediatr Surg 2001 Oct;11(5):324-7
AD - Service of Paediatric Surgery, University of Santa Maria, Santa Maria,
Brazil. Yvelise@ccs.ufsm.br
Congenital midline nasal masses are rare anomalies that occur in about
one in 20,000-40,000 live births. The most common are dermoid/epidermoid
tumors, nasal cerebral heterotopias (nasal gliomas), and nasal
encephaloceles; some have an actual or potential central nervous system
connection. Nasal gliomas are CNS masses of neurogenic origin which have
lost their intracranial connections and present as an obvious external
or intranasal mass at birth without associated surgical symptoms.
Careful evaluation is required to confirm the diagnosis and appropriate
management. The interpretation of CT and MR images can be difficult but
is useful in differentiating nasal gliomas from other congenital nasal
masses. The presence of a fibrous stalk may be associated with cranial
defects and CSF leak. Excisional biopsy allows histopathologic diagnosis
and is the definitive treatment. They are benign lesions, and
recurrences are rare, so conservative cosmetic surgical techniques
should be chosen for gliomas where there is no proven intracranial
extension. The authors report an illustrative nasal glioma case in a
one-year-old male infant with extranasal and intranasal components, and
discuss the therapeutic options.
18
UI - 11732819
AU - Orvidas LJ; Beatty CW; Weaver AL
TI -
Antrochoanal polyps in children.
SO - Am J Rhinol 2001 Sep-Oct;15(5):321-5
AD - Department of Otorhinolaryngology, Mayo Clinic and Mayo Foundation,
Rochester, Minnesota 55905, USA.
Although relatively rare, antrochoanal polyps represent one of the most
common types of polyp diagnosed in children without cystic fibrosis. In
an attempt to better define this entity and discuss treatment options,
the histories and operative reports of all 25 children (aged 17 years
and younger) diagnosed with an antrochoanal polyp between 1970 and 1997
at our institution were reviewed. All 25 children complained of nasal
obstruction on presentation; other presenting symptoms included
rhinorrhea (48%), snoring (36%), and mouth breathing (32%). All 25
patients were noted to have a mass in the nose on examination, and 16
(64%) also had a mass noted in the nasopharynx. All but 1 patient
underwent surgical removal of the polyp: intranasal avulsion only, 2
patients; Caldwell-Luc procedures, 10 patients; intranasal procedures, 8
patients; and endoscopic procedures, 4 patients. Mean time to first
recurrence was 44.5 months. Seven patients (29%) who underwent excision
at our institution experienced recurrence, 3 after endoscopic procedures
and 4 after intranasal procedures (with or without Caldwell-Luc; 1 of
these patients had a second recurrence). Complications were unusual and
included bleeding after pack removal (8.3%) and facial paresthesias
(10%). Follow-up ranged from 2 days to almost 27 years and was aided by
telephone interviews. We conclude that surgical treatment of these
lesions is safe and effective. Endoscopic removal may result in a higher
recurrence rate.
19
UI - 11732823
AU - Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
TI -
Differentiation-related p53 protein expression in nondysplastic
sinonasal inverted papillomas.
SO - Am J Rhinol 2001 Sep-Oct;15(5):347-51
AD - Department of Pathology, Military Hospital Ulm, Ulm/Donau, Germany.
To clarify p53 protein expression in nondysplastic sinonasal inverted
papillomas, archived surgical specimens from 19 patients were studied
using immunohistochemistry. Staining results were compared between
inverted papillomas and adjacent, nonpapillomatous nasal mucosa.
Further, immunoreactivity was compared between columnar (respiratory),
transitional (cuboidal), and squamous epithelium in inverted papillomas.
Positive staining was found in 17 of 19 inverted papillomas (89%).
Immunoreactivity involved predominantly basal and parabasal cells and
was either comparable or higher in inverted papillomas compared with
adjacent mucosa. In 65% of immunoreactive inverted papillomas comparable
staining results were seen between columnar (respiratory), transitional
(cuboidal), and squamous epithelium. In 35% of p53 protein-positive
inverted papillomas, enhanced immunoreactivity was observed in
transitional (cuboidal) and squamous epithelium compared with columnar
(respiratory) epithelium. Within these cases, immunoreactivity was
either comparable or higher in squamous compared with transitional
(cuboidal) epithelium. Conclusively, the expression of p53 protein is
present in 89% of nondysplastic sinonasal inverted papillomas and also
involves the adjacent, nonpapillomatous nasal mucosa. A tendency toward
increasing p53 protein expression from nonpapillomatous nasal mucosa to
inverted papilloma as well as along the metaplastic process from
columnar (respiratory) to transitional (cuboidal) and finally squamous
epithelium within inverted papillomas can be postulated.
20
UI - 11801784
AU - Boyd AS; Zhang J
TI -
Hemangioblastoma arising in the skin.
SO - Am J Dermatopathol 2001 Oct;23(5):482-4
AD - Department of Medicine (Dermatology), Vanderbilt University, Nashville,
Tennessee 37232, USA. eyebacon@aol.com
Hemangioblastomas are intracranial and intraspinal tumors arising
sporadically or in patients with von Hippel-Lindau disease. To date,
hemangioblastomas have not been described in the skin. Proliferating
clear cells with a variable vascular component are found histologically.
These clear cells stain for neuron-specific enolase but not cytokeratin
or epithelial membrane antigen, allowing them to be differentiated from
metastatic renal cell carcinoma.
21
UI - 11724258
AU - Prado GL; Itabashi Y; Noda H; Miura H; Mariya Y; Abe Y
TI -
Olfactory neuroblastoma visualized by Technetium-99m-ECD SPECT.
SO - Radiat Med 2001 Sep-Oct;19(5):267-70
AD - Department of Radiology, Hirosaki University School of Medicine, Japan.
We describe a case of olfactory neuroblastoma diagnosed by 99mTc-ECD
SPECT. Although MRI and CT are very important for delineating these
tumors, they are, by no means, specific for neuroblastomas. 131I-MIBG
scintigraphy, the standard method for imaging tumors of neural crest
origin, also failed to detect a histologically proven
esthesioneuroblastoma.
22
UI - 11810394
AU - Buhl R; Nabavi A; Fritsch M; Mehdorn HM
TI -
Nasopharyngeal extension of a craniopharyngioma in a 4 year old girl.
SO - Acta Neurochir (Wien) 2001 Dec;143(12):1283-5
AD - Department of Neurosurgery, University of Kiel, Germany.
Nasopharyngeal extension of a craniopharyngioma is very rare and usually
presents with headache, nasal obstruction and visual disturbances. We
present a case of a 4 year old girl, who became symptomatic with visual
deterioration. MRI showed a huge supra - and infrasellar cystic
craniopharyngioma with extension into the sphenoid sinus. Primary
treatment was a transnasal puncture of the cyst followed by a subfrontal
approach with removal of the tumour preserving the chiasm and optic
nerves. The visual acuity postoperatively improved while she needed
hormone replacement due to panhypopituitarism. Follow-up 12 months after
the operation showed no recurrence. This is the youngest patient of
about 27 patients reported so far in the literature.
23
UI - 11796430
AU - Henriksson G; Westrin KM; Karpati F; Wikstrom AC; Stierna P; Hjelte L
TI -
Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal
lavage fluid analysis.
SO - Chest 2002 Jan;121(1):40-7
AD - Department of Otolaryngology, Karolinska Institute, Huddinge University
Hospital, Huddinge, Sweden. Gert.Henriksson@ent.hs.sll.se
STUDY OBJECTIVES: Nasal polyps frequently appear in patients with cystic
fibrosis (CF). The aims of this study were to focus on what problems
(symptoms, endoscopic findings, and laboratory correlates) nasal polyps
cause the CF patient, and how these correlate to the total health
situation of this patient group. PATIENTS AND STUDY DESIGN: The clinical
histories, endoscopic investigations of the nasal cavity, and analyses
of nasal lavage fluid of 44 patients with CF complicated with nasal
polyposis have been compared with those of 67 CF control subjects. The
patients were examined at annual control examinations (with pulmonary
tests, working capacity, liver tests, and bacterial and blood tests)
from 1995 to 1996 at Stockholm Cystic Fibrosis Center, Huddinge
University Hospital. All patients were > 2 years of age. The endoscopic
findings were related to the actual pulmonary function, inflammatory
blood parameters, colonizing pathogens, antibodies (Staphylococcus
aureus and Pseudomonas aeruginosa), and genotype. RESULTS: The patients
with nasal polyps differed with respect to chronic colonization of P
aeruginosa in sputum samples and had a higher occurrence of serum
antibodies against the same species. The two groups did not differ in
pulmonary functions, inflammatory parameters, or genotype. The polyps
found were mainly small (within the meatus media) and gave no
significant increase in ongoing clinical symptoms such as rhinorrhea,
nasal obstruction, or hyposmia. Neither was any significantly marked
finding concerning the nose (mucosal swellings, secretion, etc.) made in
the polyp patients. The patients with CF scored slightly lower in a
smell identification test in comparison with the healthy control group.
The nasal lavage fluid was analyzed (in 93 of the 111 patients) for the
occurrence of P aeruginosa (by polymerase-chain reaction [PCR]),
interleukin [IL]-5, IL-8, and lysozyme. The lysozyme and IL-8 content
was equal in the two CF groups but increased in comparison with the
healthy control group. P aeruginosa was not detected with PCR in any
nasal lavage fluid. No measurable levels of IL-5 in the nasal lavage
were found. CONCLUSIONS: There was a higher frequency of chronic
colonization of P aeruginosa in the lower respiratory tract in patients
with nasal polyps. Otherwise, nonsevere nasal polyposis was not an
indicator of lower respiratory tract morbidity in CF patients.
24
UI - 11806965
AU - Zammit-Maempel I; Hide IG; Hill J
TI -
Case of the month. A hearing problem with a difference.
SO - Br J Radiol 2002 Jan;75(889):85-6
AD - Department of Radiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN,
UK.
25
UI - 11819912
AU - Crampette L
TI -
[Nasal-paranasal sinus polyposis]
SO - Presse Med 2001 Dec 22-29;30(39-40 Pt 2):44-50
1. POLYPOSIS AND ALLERGY: Nasosinusal polyposis and allergy must be
considered as two distinct conditions. 2. POLYPOSIS: Approximately 1% of
the general population has nasosinusal polyposis, a condition strongly
associated with asthma (about one-third of the patients with polyposis
have asthma). Patients with nasosinusal should undergo a complete
respiratory examination in order to search for asthma or an asthma
equivalent. 3. EOSINOPHILS: Eosiophils play a crucial role in the
inflammatory reaction, releasing almost all the known inflammatory
mediators: cytokines, chemokines and growth factors. 4. EPITHELIAL CELL:
The epithelial cell probably plays a very important role. 5. MEDICAL
TREATMENT: Long-duration intranasal corticotherapy is the basis of drug
treatment. Short courses of oral corticosteroids may be useful during
acute episodes in inflammation. The exact effect of oral corticosterid
is not clearly elucidated but it is known that non-steroidal
antiinflammatory drugs (NSAID) are contraindicated in polyposis. 6.
SURGICAL TREATMENT: Surgery is reserved for medical failures or for
patients with a contraindication for drug therapy. Endonasal
ethmoidectomy is the basis treatment. 7. PERSPECTIVES: Better
understanding of the underlying pathophysiology and the probable genetic
component will determine future treatments. Perspectives include
antiinflammatory drugs currently reserved for other conditions
(antileucotriene, antiTNFa, IL-18) and elaboration of new
antiinflammatory drugs.
26
UI - 11843557
AU - Chung J; Park ST; Jang J
TI -
Fine needle aspiration cytology of metastatic olfactory neuroblastoma: a
case report.
SO - Acta Cytol 2002 Jan-Feb;46(1):40-5
AD - Department of Diagnostic Pathology, Asan Kangnung Hospital, KangNungSi,
South Korea. gzz@ghil.com
BACKGROUND: Olfactory neuroblastoma (ONB) is an uncommon tumor,
presenting as a polypoid mass arising from the upper nasal cavity. This
tumor has been seldom diagnosed by direct fine needle aspiration (FNA).
CASE: Metastatic ONB was diagnosed by FNA. The patient was a 40-year-old
female with a polypoid mass in the nasal cavity and ipsilateral cervical
lymphadenopathy. The punch biopsy of the nasal tumor revealed a smudged
small round cell neoplasm with neuroendocrine differentiation,
consistent with ONB. In FNA smears from the cervical lymph node, there
were well-preserved, small, monotonous cells with hyperchromatic nuclei,
fibrillary cytoplasm and indistinct cell borders. Also noteworthy were
occasional pseudorosettes as well as rare true rosettes. By
immunocytochemistry, tumor cells were positive for cytokeratin,
chromogranin and synaptophysin. CONCLUSION: ONB, like adrenal
neuroblastoma, shows distinctive cytologic features, including a rosette
or pseudorosette and fibrillary network. FNA can accurately demonstrate
these characteristic findings, and in some cases it may be a better
diagnostic modality than incisional biopsy.
27
UI - 11802479
AU - Benoliel P
TI -
[Treatment of sino-nasal polyposis by Candida albicans immunotherapy:
apropos of 4 cases]
SO - Allerg Immunol (Paris) 2001 Dec;33(10):388-94
The NSP is an inflammatory chronic disease of the mucous of nose and
sinuses. None etiological treatment is known up to now. The aim of this
study is to consider a model of autoallergy as etiology for NSP proven
by specific immunotherapy (STI) to Candida albicans (CA). METHODS: Four
NSP treated by SIT to Candida albicans are reported. The patients are
treated either by subcutaneous injections or sublingual drops. The
frequency is one injection per week or a few drops per day (absorbed
extract on calcium phosphate or aqueous Stallergenes). RESULTS: The
cumulated doses varies from 465 Index of Concentration (IC) to 117500 IC
on a period of 3 to 4 years. The results are evaluated according the
rhino-sinusal semeiology, the intensity of symptoms, and the stage of
polyposis. The SIT is also active on both a late and an immediate
components for the symptoms, and the cutaneous tests. The results are
significant 60% to 80% of improvement. The viral or bacterial infections
reactivate both types of hypersensitivity and they are prevented by SIT.
The nasal hyperactivity observed as a more advanced non specific stage
of the PNS is also improved by ITS. In two of the clinical cases, the
pollenogenic seasonal obstruction is added to the nasal perennial
obstruction in a sharp manner. The pollenogenic allergy is also improved
after SIT to CA without any other associated SIT. CONCLUSION: The model
of autoallergy already proven as etiology for atopic dermatitis can
serve as a base of exploration of PNS. That is showing the presence of
IgE antibody corresponding to intracellular proteinic autoallergens
having an analogy to environment allergens. The allergy to Candida
albicans can thus be considered as an etiology of the PNS.
28
UI - 11795767
AU - Scott M; Brooker DS; Davis RI
TI -
Paraganglioma of the nasal cavity.
SO - Ulster Med J 2001 Nov;70(2):149-51
AD - Department of Pathology, Royal Hospitals, Belfast.
29
UI - 11738698
AU - Wong BY; Hui Y; Lam KY; Wei WI
TI -
Neurothekeoma of the paranasal sinuses in a 3-year-old boy.
SO - Int J Pediatr Otorhinolaryngol 2002 Jan 11;62(1):69-73
AD - Department of Otorhinolaryngology, Division of Otorhinolaryngology Head
and Neck Surgery, Queen Mary Hospital, The University of Hong Kong, 102
Pokfulam Road, SAR, Hong Kong, People's Republic of China.
yhbird@yahoo.com
Neurothekeoma is a benign soft tissue tumor commonly located on the
skin. In this report, a 3-year-old boy presented with restricted right
eye movement and decrease in visual acuity. The patient was found to
have a 6-cm neurothekeoma involving the maxillary and ethmoid sinuses.
To our knowledge, this is the first reported case of neurothekeoma with
involvement of the maxillary and ethmoid sinuses. This uncommon lesion
should be considered as the differential diagnosis of pediatric soft
tissue tumors in the head and neck region.
30
UI - 11849270
AU - Tremblay JF; Bernstein SC
TI -
Hatchet flap.
SO - Dermatol Surg 2001 Dec;27(12):1049-51
AD - University of Montreal, Quebec, Canada. jeanfrancois.tremblay@yahoo.com
31
UI - 11843456
AU - Runte C; Runte B; Dirksen D; Bollmann F; Micke O; Schafer U; Willich N
TI -
A pivoting appliance for intracavitary brachytherapy in patients with
reduced mouth opening.
SO - Int J Prosthodont 2001 Mar-Apr;14(2):178-82
AD - Department of Prosthodontics, University of Muenster, Germany.
crunte@uni-muenster.de
PURPOSE: The risks of radiotherapy to normal tissues are well known. In
many cases, a tumor patient suffering a relapse cannot undergo
radiotherapy a second time. One exception may be the local application
of brachytherapy. Afterloading devices allow the position of radiating
materials near the site for treatment exactly according to
three-dimensional treatment planning. This report shows the technical
procedure for the fabrication of an intracavitary afterloading radiation
device. MATERIALS AND METHODS: A 48-year-old woman who had received
neutron radiotherapy and tumor surgery for adenoid cystic carcinoma had
to be treated for relapse. The mouth opening was limited to 15 mm. The
mixing tip of a silicone impression system was used as an axis for a
pivoting appliance. RESULTS: Two years after reradiation, the patient
was free of relapse symptoms, although an increased limitation of mouth
opening was recorded. CONCLUSION: Even if the mouth opening is severely
limited after tumor surgery and/or radiation, intracavitary
brachytherapy still can be performed in edentulous patients using a
pivoting device.
32
UI - 11765447
AU - Poludniewska B; Rogowski M; Soroczynska J
TI -
[Preliminary assessment of the role of IL-5 in the pathogenesis of nasal
polyps]
SO - Otolaryngol Pol 2001;55(3):303-5
AD - Klinika Otolaryngologii Akademii Medycznej w Bialymstoku.
Preliminary results of IL-5 levels in homogenates derived from nasal
polyps tissue are presented. The IL-5 concentration was assessed by
immunoenzymatic method (ELISA, R&D, Systems Minneapolis). 26 patients at
age 21-60 years were examined. IL-5 cevels were higher in polips with
allergic and were examined. IL-5 levels were higher in polips with
allergic and aspirin idiocracy background compared with inflammatory
polips. In addition, IL-5 levels were increased in recurrent polips.
33
UI - 11815930
AU - Akmansu H; Eryilmaz A; Dagli M; Korkmaz H
TI -
Endoscopic removal of paranasal sinus osteoma: a case report.
SO - J Oral Maxillofac Surg 2002 Feb;60(2):230-2
AD - Department of Otolaryngology and Head and Neck Surgery, Numune Hospital,
Ankara, Turkey.
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
